| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |